Antimicrobianos

Amicoumacin A is an antibiotic compound, which is derived from the bacterium Bacillus subtilis. This natural source is known for its production of a variety of biologically active compounds that contribute to its utility in numerous scientific contexts. The mode of action of Amicoumacin A involves the inhibition of bacterial protein synthesis by targeting the ribosomal subunit. Specifically, it interferes with the translation process, effectively disrupting the growth and proliferation of susceptible bacterial strains.

Amicoumacin A is primarily utilized in research settings to study bacterial resistance mechanisms, as well as to explore novel antibacterial therapies. Its application in scientific research extends to examining its potential synergistic effects with other antimicrobial agents, and it serves as a model compound for understanding ribosomal inhibition. The study of Amicoumacin A not only contributes to the broader field of antibiotic development but also offers insights into the molecular interactions that underlie bacterial protein synthesis and antibiotic resistance. This compound's unique properties make it an important subject of investigation for microbiologists and pharmacologists alike, emphasizing its relevance in the ongoing battle against antibiotic-resistant pathogens.

Pefloxacin mesylate is a fluoroquinolone antibiotic with action on bacterial DNA gyrase and topoisomerase IV and is used for treating bacterial infections, including urinary and respiratory tract infections.

Anti-viral; NS5A protein inhibitor

Inhibitor of HIV-1 integrase strand transfer; antiviral

Monensin sodium is a polyether antibiotic with action on ion transport across bacterial cell membranes and is used for preventing coccidiosis and improving feed efficiency in livestock.

Roxithromycin is a macrolide antibiotic with action on bacterial protein synthesis by binding to the 50S ribosomal subunit and is used for treating respiratory, skin, and soft tissue infections.

Flubendazole is a benzimidazole anthelmintic with action on microtubule formation in parasites and is used for treating intestinal worms in humans and animals.

Posaconazole is an antifungal agent that inhibits the 14-alpha demethylase enzyme which is responsible for the synthesis of the fungal cell wall component, ergosterol. This demethylase enzyme synthesizes ergosterol through converting lanosterol to ergosterol. Therefore Posaconazole prevents the formation of fungal cell walls with the appropriate membrane permeability thus leading to fungal cell lysis. Posaconazole can be used as an antifungal drug to treat opportunistic fungal infections in immunocompromised individuals such as HIV patients. Moreover it is shown to inflict its inhibitory activity against common pathogenic fungus such as Candida and Aspergillus species but also Mucorales and some Fusarium species, which are less common.

Inhibitor of cell-wall synthesis; cephalosporin class

Triazavirin is an antiviral drug developed against SAR-CoV-2. The action of triazavirin might be due to its ability to inhibit the Mpro protease from SARS viruses. Triazavirin has been clinically tested in the treatment of COVID-19 patients.

Ledipasvir D-tartrate is an antiviral compound, which is a direct-acting antiviral agent used in the treatment of hepatitis C virus (HCV) infection. It originates from synthetic sources designed to inhibit the replication of specific viral proteins. Ledipasvir functions by targeting the NS5A protein of the hepatitis C virus, a key component necessary for viral replication. By binding to this protein, Ledipasvir disrupts and inhibits the HCV replication complex, effectively suppressing the viral load in patients.

Pefloxacin is a mesylate prodrug that is converted to pefloxacin in the body. The optimum concentration for pefloxacin is 2 µg/mL, and it has been shown to be active against gram-positive bacteria such as Streptococcus pneumoniae, group A beta-hemolytic streptococci, and Enterococcus faecalis. Pefloxacin has also been shown to inhibit the growth of human leukemia cells (HL-60) and drug interactions have been documented with this drug. Pefloxacin is not active against Mycobacterium tuberculosis or Mycobacterium avium complex.

Cephalosporin antibiotic; interferes with cell wall biosynthesis

Potassium clavulanate is a beta-lactamase inhibitor and an antibacterial agent. The presence of potassium clavulanate in culture media inhibits the activity of beta-lactamases, which are enzymes that confer resistance to penicillin and other beta-lactam antibiotics. It also has been shown to be active against bacterial infections such as tuberculosis, sepsis, and pneumonia, where it can inhibit the growth of bacteria by interfering with their ability to form cell walls. Potassium clavulanate is also used as an antimicrobial agent for blood culture technique and antimicrobial treatment.

Netropsin dihydrochloride is a pyrrole-amidine antibiotic with action on AT-rich sequences of DNA to inhibit replication and is used for research on DNA-binding properties and antiviral activity.

Ciprofloxacinhydrochloride, the hydrochloride salt form of ciprofloxacin is afluoroquinolone that exerts its antibacterial activity by inhibiting DNK gyrase (topoisomerase II) which inhibits relaxation of supercoiled DNA and promotes breakage of double-stranded DNA. Also, ciprofloxacine inhibits cytochrome P450 CYP1A2. Ciprofloxacine is a broad spectrum antibiotic,effective against Gram positive and Gram negative bacteria: Enterobacteriaceae, H. influenzae, N. gonorrhoeae, Campylobacter spp and Pseudomonas with clinical application for complicated urinary tract infections, respiratory infections caused by Pseudomonas aeruginosa strains inpatients with cystic fibrosis, invasive otitis externa caused by P. aeruginosa, chronic osteomyelitis caused by gram negative organisms, eradication of Salmonella, gonorrhoea, bacterial prostatitis, cervicitis, anthrax.

Cefiderocol is a siderophore cephalosporin antibiotic with action on bacterial cell wall synthesis, particularly targeting multidrug-resistant gram-negative bacteria and is used for treating complicated urinary tract infections and hospital-acquired pneumonia.

Anthracycline is a class of chemotherapy drugs, which are anthraquinone antibiotics derived from the bacterial genus Streptomyces. They exert their therapeutic effects primarily through intercalation into DNA, disrupting the function of enzymes such as topoisomerase II, thus preventing the transcription and replication processes in rapidly dividing cancer cells. Furthermore, they generate free radicals, leading to oxidative stress and subsequent cell damage. These mechanisms collectively result in apoptosis of malignant cells. Anthracyclines are utilized extensively in oncology for the treatment of various malignancies, including leukemias, lymphomas, breast cancer, and sarcomas. The efficacy of anthracyclines in inhibiting tumor growth must be balanced against their cardiotoxic potential, which is a significant consideration in their clinical use. This dual nature makes them both pivotal and challenging in chemotherapy regimens, necessitating careful management and monitoring throughout treatment.

Abacavir is an antiviral nucleoside reverse transcriptase inhibitor that is used for the treatment of HIV. This drug inhibits the activity of HIV-1 reverse transcriptase (RT) both by competing with dGTP and by its incorporation into viral DNA.

Ticarcillin disodium salt is a beta-lactam antibiotic that has in vitro activity against Gram-positive and Gram-negative bacteria. Ticarcillin is active against penicillinase-producing strains of Staphylococcus aureus, Enterobacter aerogenes, Proteus mirabilis, Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Serratia marcescens, Streptococcus pyogenes, Streptococcus faecalis, and Streptococcus pneumoniae. Furthermore, it inhibits transpeptidase activity of the cell wall of bacteria which prevents peptidoglycan synthesis. It is bactericidal for many bacteria at low concentrations.